195 related articles for article (PubMed ID: 38663961)
21. How location governs toll-like receptor signaling.
Chaturvedi A; Pierce SK
Traffic; 2009 Jun; 10(6):621-8. PubMed ID: 19302269
[TBL] [Abstract][Full Text] [Related]
22. Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.
Paracatu LC; Schuettpelz LG
Front Immunol; 2020; 11():1236. PubMed ID: 32625214
[TBL] [Abstract][Full Text] [Related]
23. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
[TBL] [Abstract][Full Text] [Related]
24. [Signal transduction pathways mediated by Toll-like receptors and their relations with fungal keratitis].
Chen P; Xie LX
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):80-4. PubMed ID: 22490919
[TBL] [Abstract][Full Text] [Related]
25. Interdependencies between Toll-like receptors in Leishmania infection.
Shukla D; Patidar A; Sarma U; Chauhan P; Pandey SP; Chandel HS; Bodhale N; Ghosh SK; Guzman CA; Ebensen T; Silvestre R; Sarkar A; Saha B; Bhattacharjee S
Immunology; 2021 Sep; 164(1):173-189. PubMed ID: 33964011
[TBL] [Abstract][Full Text] [Related]
26. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
Kumar V
Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
[TBL] [Abstract][Full Text] [Related]
28. Structure of fish Toll-like receptors (TLR) and NOD-like receptors (NLR).
Sahoo BR
Int J Biol Macromol; 2020 Oct; 161():1602-1617. PubMed ID: 32755705
[TBL] [Abstract][Full Text] [Related]
29. Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications.
Chen YH; Wu KH; Wu HP
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732254
[TBL] [Abstract][Full Text] [Related]
30. Targeting Toll-like receptors with small molecule agents.
Wang X; Smith C; Yin H
Chem Soc Rev; 2013 Jun; 42(12):4859-66. PubMed ID: 23503527
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Toll-like receptor signaling pathways in innate immune responses.
Qian C; Cao X
Ann N Y Acad Sci; 2013 Apr; 1283():67-74. PubMed ID: 23163321
[TBL] [Abstract][Full Text] [Related]
32. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy.
Tran TH; Tran TTP; Truong DH; Nguyen HT; Pham TT; Yong CS; Kim JO
Acta Biomater; 2019 Aug; 94():82-96. PubMed ID: 31129358
[TBL] [Abstract][Full Text] [Related]
34. Toll-Like Receptors Signaling in the Tumor Microenvironment.
McCall KD; Muccioli M; Benencia F
Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
[TBL] [Abstract][Full Text] [Related]
35. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
[TBL] [Abstract][Full Text] [Related]
36. Targeting Toll-Like Receptors for Cancer Therapy.
Braunstein MJ; Kucharczyk J; Adams S
Target Oncol; 2018 Oct; 13(5):583-598. PubMed ID: 30229471
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in the development of Toll-like receptor (TLR) antagonists.
Patra MC; Choi S
Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive review on the dynamic role of toll-like receptors (TLRs) in frontier aquaculture research and as a promising avenue for fish disease management.
Mahapatra S; Ganguly B; Pani S; Saha A; Samanta M
Int J Biol Macromol; 2023 Dec; 253(Pt 1):126541. PubMed ID: 37648127
[TBL] [Abstract][Full Text] [Related]
39. The application of Toll like receptors for cancer therapy.
So EY; Ouchi T
Int J Biol Sci; 2010 Nov; 6(7):675-81. PubMed ID: 21060729
[TBL] [Abstract][Full Text] [Related]
40. Toll-Like Receptor-Based Strategies for Cancer Immunotherapy.
Pahlavanneshan S; Sayadmanesh A; Ebrahimiyan H; Basiri M
J Immunol Res; 2021; 2021():9912188. PubMed ID: 34124272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
